{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:15:35Z","timestamp":1759331735199},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.lungcan.2005.11.015","type":"journal-article","created":{"date-parts":[[2006,2,21]],"date-time":"2006-02-21T07:14:56Z","timestamp":1140506096000},"page":"75-81","source":"Crossref","is-referenced-by-count":11,"title":["Randomized phase II study of gemcitabine plus cisplatin versus etoposide plus cisplatin for the treatment of locally advanced or metastatic non-small cell lung cancer: Korean Cancer Study Group experience"],"prefix":"10.1016","volume":"52","author":[{"given":"Jee Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hae","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keunchil","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Won","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Young","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeul Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baek Yeol","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2005.11.015_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/4691","article-title":"Tobacco\u2014the growing epidemic","volume":"5","author":"Peto","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.lungcan.2005.11.015_bib2","unstructured":"Headquarter of Korea Central Cancer Registry. 2002 annual report of the Korea Central Cancer Registry, http:\/\/www.ncc.re.kr."},{"key":"10.1016\/j.lungcan.2005.11.015_bib3","series-title":"Cancer: principles and practice of oncology","first-page":"753","article-title":"Cancer of the lung","author":"Schrump","year":"2005"},{"key":"10.1016\/j.lungcan.2005.11.015_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.lungcan.2005.11.015_bib5","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1200\/JCO.1999.17.10.3188","article-title":"Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life","volume":"17","author":"Cullen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-5002(99)00017-3","article-title":"Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy","volume":"24","author":"Thongprasert","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2005.11.015_bib7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0959-8049(97)10122-8","article-title":"Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only: a multicentre randomised phase III trial. Joint Lung Cancer Study Group","volume":"34","author":"Helsing","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2005.11.015_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/thx.2003.020164","article-title":"Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life","volume":"59","author":"Spiro","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2005.11.015_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/JCO.1999.17.1.12","article-title":"Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer","volume":"17","author":"Cardenal","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1200\/JCO.2000.18.3.623","article-title":"Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial","volume":"18","author":"Bonomi","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib12","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.1998.16.6.2133","article-title":"Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"16","author":"Giaccone","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2004.06.114","article-title":"Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: the Japanese Taxotere Lung Cancer Study Group","volume":"22","author":"Kubota","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2005.11.015_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2005.11.015_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2004.10.014","article-title":"Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes","volume":"47","author":"Le Chevalier","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2005.11.015_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/annonc\/mdg118","article-title":"Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients","volume":"14","author":"Millward","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib18","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial)","volume":"21","author":"Fukuoka","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3816\/CLC.2002.n.007","article-title":"Results of recent Japanese clinical trials in lung cancer","volume":"3","author":"Ohe","year":"2002","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2005.11.015_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jclinepi.2003.11.002","article-title":"In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival","volume":"57","author":"Tammemagi","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib21","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2005.11.015_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jjco\/hyf013","article-title":"Phase I\/II study of 3-week cycle cisplatin-gemcitabine in advanced non-small cell lung cancer","volume":"32","author":"Kusaba","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.lungcan.2005.11.015_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10147-001-8029-5","article-title":"A study of the combination of gemcitabine hydrochloride (LY 188011) and cisplatin in non-small-cell lung cancer: 3-week schedule","volume":"6","author":"Kunikane","year":"2001","journal-title":"Int J Clin Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500206000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T21:16:33Z","timestamp":1555449393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500206000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0169500206000262"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2005.11.015","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}